Press coverage about Castlight Health (NYSE:CSLT) has trended somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Castlight Health earned a news impact score of 0.13 on Accern’s scale. Accern also assigned news articles about the software maker an impact score of 45.1809261321483 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:
- Castlight Health (CSLT) Upgraded to Sell at ValuEngine (americanbankingnews.com)
- Castlight Health (CSLT) PT Lowered to $6.30 at Chardan Capital (americanbankingnews.com)
- Castlight (CSLT) Down More Than 5%: What’s Hurting the Stock? (finance.yahoo.com)
- Castlight Health (CSLT) Lowered to “Strong Sell” at BidaskClub (americanbankingnews.com)
CSLT stock traded down $0.15 during trading on Friday, hitting $3.45. 260,498 shares of the company’s stock were exchanged, compared to its average volume of 244,071. The stock has a market cap of $486.98, a price-to-earnings ratio of -13.27 and a beta of 1.39. Castlight Health has a 52-week low of $3.15 and a 52-week high of $4.75. The company has a quick ratio of 2.06, a current ratio of 2.06 and a debt-to-equity ratio of 0.03.
CSLT has been the subject of a number of analyst reports. Cantor Fitzgerald raised Castlight Health from a “neutral” rating to an “overweight” rating and set a $5.00 price objective for the company in a research report on Tuesday, January 30th. Zacks Investment Research downgraded Castlight Health from a “buy” rating to a “hold” rating in a research report on Monday, January 1st. Chardan Capital reissued a “buy” rating and set a $5.75 price objective (down from $6.30) on shares of Castlight Health in a research report on Thursday, February 22nd. Finally, ValuEngine raised Castlight Health from a “strong sell” rating to a “sell” rating in a research report on Wednesday. Four investment analysts have rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. Castlight Health presently has a consensus rating of “Hold” and a consensus price target of $5.04.
In related news, CEO John C. Doyle sold 10,644 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total transaction of $38,637.72. Following the completion of the sale, the chief executive officer now owns 157,422 shares in the company, valued at $571,441.86. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Mangini Siobhan Nolan sold 18,201 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total value of $66,069.63. Following the sale, the chief financial officer now owns 120,788 shares of the company’s stock, valued at approximately $438,460.44. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,184 shares of company stock valued at $120,762. 37.43% of the stock is owned by company insiders.
WARNING: This article was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3338870/castlight-health-cslt-receives-daily-coverage-optimism-rating-of-0-13.html.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.